Old Web
English
Sign In
Acemap
>
authorDetail
>
Nicholas D. Rintala
Nicholas D. Rintala
Infectious Disease Research Institute
Adjuvant
Antibody
TLR4
Immune system
Inflammasome
4
Papers
96
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Preclinical optimization of an enterotoxigenic Escherichia coli adjuvanted subunit vaccine using response surface design of experiments.
2020
David Poncet
Catherine Hessler
Hong Liang
Sylviane Gautheron
Michelle Sergent
Nicholas D. Rintala
Emilie Seydoux
Po-wei D. Huang
David Argilla
Sophie Ruiz
Jon Heinrichs
Milton Maciel
Mark T. Orr
Show All
Source
Cite
Save
Citations (2)
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
2019
Mark T. Orr
Amit P. Khandhar
Emilie Seydoux
Hong Liang
Emily Gage
Traci Mikasa
Elyse L. Beebe
Nicholas D. Rintala
Karin H. Persson
Anwar Ahniyaz
Darrick Carter
Steven G. Reed
Christopher B. Fox
Show All
Source
Cite
Save
Citations (58)
The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine.
2019
Hong Liang
David Poncet
Emilie Seydoux
Nicholas D. Rintala
Milton Maciel
Sophie Ruiz
Mark T. Orr
Show All
Source
Cite
Save
Citations (10)
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses
2018
Journal of Immunology
Emilie Seydoux
Hong Liang
Natasha Dubois Cauwelaert
Michelle Archer
Nicholas D. Rintala
Ryan M. Kramer
Darrick Carter
Christopher B. Fox
Mark T. Orr
Show All
Source
Cite
Save
Citations (26)
1